Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin

See also
Status	Clinical Trial	Phase
Completed	`NCT00412464` - Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis	Phase 1
Completed	`NCT00456326` - Heparin-Induced Thrombocytopenia Registry	N/A
Terminated	`NCT00673439` - Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)	Phase 2
Active, not recruiting	`NCT00198575` - A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients	N/A
Completed	`NCT00283322` - Heparin Antibodies in Intensive Care Unit Patients (HAICU)	N/A
Not yet recruiting	`NCT05586854` - Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia	N/A
Not yet recruiting	`NCT03269019` - Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia	N/A
Not yet recruiting	`NCT06066762` - Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.
Terminated	`NCT03809481` - Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban	Phase 3
Completed	`NCT05325346` - A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects	Phase 1
Recruiting	`NCT02717039` - Pharmacogenomics of Heparin-Induced Thrombocytopenia
Completed	`NCT02526485` - Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2
Completed	`NCT00748839` - Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical	N/A
Recruiting	`NCT05783895` - Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery
Not yet recruiting	`NCT04782843` - Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care.
Completed	`NCT00198588` - Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia	Phase 3
Recruiting	`NCT04842760` - PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
Terminated	`NCT01598168` - Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia	Phase 3
Completed	`NCT01654848` - Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients	N/A
Withdrawn	`NCT00603824` - Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)	Phase 4

NCT number	NCT00759083
Study type	Interventional
Source	The Medicines Company
Contact
Status	Withdrawn
Phase	Phase 4
Start date	September 2008
Completion date	May 10, 2010

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms